Part of funding portal member: truCrowd, Inc.
Mobile Menu

Gulf Coast Canna Meds, Inc

Medical Marijuana Grower, Extractor and Dispensary. Soon.

Closed on 05/01/18

87% funded (of minimum target)



funding goal 

$20k - $1070k

funding goal 

Regulation CF

exemption used 

Regulation CF

exemption used 


pre money valuation 


min investment 


amount committed 



Investment Type

SAFE+REV, or Simple Agreement for Future Equity and a Revenue Participation Rights and have two exits: the Revenue Participation that will give you 3X multiple return on your money, and the second one is the SAFE that will convert your money into equity when we will go public or get bought.

Safe: Simple Agreement for Future Equity

$8.1 Mil Valuation Cap

rev: revenue participation

5% Revenue Split, 3x Returns

Why invest in legal cannabis?

National Cannabis Market Sales & Projections ($ in Billions)
  • The legal cannabis industry is the fastest growing industry in America
  • National sales soared to $6.7 billion in 2016, up 17.4% from 2014 (ArcView Market Research.)
  • The legal market is expected to grow to $10 billion in sales for 2017, and by 2021 nearly $22.6 billion nationally.

And the industry is only in its infancy. Many states have begun or passed legislation but lack the infrastructure for growers, processing facilities, and retail dispensaries.


Top 5 U.S. Medical Cannbis Markets in 2020
Florida is poised to be the 2nd largest market
  • Florida is the third largest state by population (20.3 million and growing (Bureau of Economic and Business Research at the University of Florida.)
  • Florida has the highest proportion of the population over the age of 65 (19.1%) matching the demographic market for medical cannabis.
  • Florida's patients registry with the Office of Medical Marijuana Use has grown from 17K to 64K in the past six months. (276% Growth)
  • Florida Senate Bill 8-A, passed July (2017), expanded the patient's treatable conditions from two to nine.
  • Five more companies have been licensed already and nine more companies will be licensed to produce and distribute products across the state.
  • And when the patient registry reaches 100K, more company licenses are slated to issue.

Best of all

Aside from the aging population, Florida is a great medicinal cannabis market because

  • Growing conditions can be made favorable in Florida
  • The barriers to entry for non-Florida companies are fierce. Due to the requirement for vertical integration- all growing, processing, and dispensing are the responsibility of the license-holder. The threat of interstate market share is unlikely.

Why invest with Gulf Coast Canna Meds?

THE Most Prestigious Medical Cannabis Dream Team

The Florida market is poised to explode in the medical cannabis industry that is already booming in its infancy around the country. Gulf Coast Canna Meds is THE Dream Team of national experts with the premier reputations to navigate the logistics in all facets of cannabis cultivation and sales including: operations, security, business leadership, legal, healthcare, finance, accounting, formulation, franchising, lobbying and more. GCCM was formed by industry leaders to win one of the select Florida licenses which requires strict and rigorous criteria including vertical integration (cannabis cultivation, processing, and dispensing by one company.)

vertical integration noun the combination in one company of two or more stages of production normally operated by separate companies.

Upon receiving one of the recently expanded Florida licenses (Florida legislature Senate Bill 8A and Amendment 2), GCCM will operate a cultivation facility, processing facility and a dispensary/treatment center in the Tampa-St. Petersburg- Clearwater metro area. Florida has great opportunity in legal cannabis is already expected to be the 2nd largest market in the country. Gulf Coast Canna Meds intends to be the community leader and future standard of excellence in cultivation, extraction, and cannabis dispensing in Florida. Our competitive advantages include: Florida agriculture experience, cultivation methods including organic hydroponics, formulations licensed from the world-leader in medical cannabis (Constance Therapeutics), educational approach to patients, confidentiality, security and enterprise management.

Investment Type

SAFE+REV, or Simple Agreement for Future Equity and a Revenue Participation Rights and have two exits: the Revenue Participation that will give you 3X multiple return on your money, and the second one is the SAFE that will convert your money into equity when we will go public or get bought.

Safe: Simple Agreement for Future Equity

$8.1 Mil Valuation Cap

rev: revenue participation

5% Revenue Split, 3x Returns

The 6-part Gulf Coast Canna Meds formula for success

In accordance with licensing requirements, Gulf Coast Canna Meds (GCCM) will run a vertically integrated medical cannabis business, to include cultivation, extraction, processing, manufacturing, distribution, and dispensing operations. GCCM will cultivate unique strains with distinct cannabinoid profiles and produce finished products such as medical cannabis concentrates, vaporizer cartridges, topicals and other infused products. GCCM will sell its branded products at its own dispensary locations and to other MMTCs around the state of Florida.
GCCM will cultivate seeds and clones of popular strains to add to the company's product line. GCCM's breeding program will create signature strains that have specific benefits for various qualifying conditions. The breeding program will focus exclusively on breeding plants that contain the cannabinoid ratios needed to alleviate the suffering of patients. Feedback from local physicians, patients, and other MMTCs will be essential for guiding the breeding project.
GCCM will internally cultivate all the cannabis used in the production of its medical cannabis products. This practice will ensure that all constituent materials meet GCCM's rigorous quality standards and will maintain consistency throughout the product line and earn consumer and medical trust. Consumers will develop product loyalty and be able to reorder the products with consistent results.
GCCM plans to operate multiple dispensaries. The company will maintain a competitive edge by offering diverse products with various cannabinoid compositions that originate from GCCM cultivation and processing facilities. As a result of the vertical integration of GCCM operations, the company will offer superior products compared to dispensaries relying on wholesale vendor accounts to supply medical cannabis. GCCM will provide the highest quality product in the market and be known as the trusted source and obvious choice in a new market.
GCCM's Skilled dispensary technicians will assist patients in personable, face-to-face interactions. GCCM dispensaries will fully accommodate people with disabilities and the elderly, two critical demographics about whom GCCM cares deeply in regard to quality of life. GCCM dispensaries will be sleek, clean, and designed like a modern pharmacy.
As part of the GCCM dispensary experience, dispensary technicians will make sure to accommodate all inquiries about medical cannabis. GCCM will take care to protect patient data and guarantee privacy when serving patients, and the company's inventory systems will ensure a complete seed-to-sale traceability. This practice will streamline company operations and demonstrate responsibility at each step of production.

Invest in the dream Team

Lori Daugherty


With 25+ years experience, Lori is a proven senior executive/CEO revered in the medical industry for enterprise strategies to improve financial performance, drive customer penetration with revenue growth 30%+, and increase bottom line growth (more than 25% in just 6 months.)

Lori's operational, financial, and strategic genius has benefited more than a dozen organizations for whom she has served in an executive or Board position.

With a very successful history of overhauling, streamlining, restructuring, merging, acquiring, and navigating private equity for organizations at the $450 M revenue-size, Lori has agreed to captain GCCM's venture. She recognizes the tremendous business and humanitarian opportunity in Florida in the medical cannabis market.

Lori's vast professional experience in the hospice industry and home health, as well as, personal experience caring for terminally ill friends and family fuels Lori's passion to provide reputable medical cannabis solutions. She has witnessed the traditional medicinal struggle between extreme pain and extreme pain control which destroys the patient's quality of life. She strives to bring reputable standardization and coaching to eliminate the stigma of medicinal cannabis.

David Kitenplon

Chief Financial Officer

Dave has been a Senior Vice President and managing partner in many investment, construction and real estate companies. Before his extensive finance career, Dave created sales presentations for the world's largest IT company and installed the first proprietary Florida Bank ATM system. He serves on Board of Directors for Largo Medical Center and is involved in various community projects.

Michael Welch

Chief Marketing Officer

Michael enjoyed a long career in marketing, advertising and production and is now responsible for public affairs and community outreach for Gulf Coast Canna Meds.

Cannabis is one of nature's greatest gifts for health and wellness, and he appreciates the opportunity to be involved with Gulf Coast Canna Meds, a company dedicated to the public good.

Lonnie Orns

Chief Operations Officer

With over 25 years operating a premiere national franchise, Lonnie and his team grew from 5 locations to three businesses and 92 locations. As a sales and expansion franchise expert Lonnie's companies have won numerous awards for sales, operations, and innovation in growth.

Andrew E. Hano

Medical Director

Andrew is a hematologist/medical oncologist in Pinellas County, Florida for 32 years, retiring from private practice in 2015. He is recognized as honorary staff at Largo Medical Center and a member of the American Society of Clinical Oncology and the American Osteopathic Association.

Oscar Mouton

Chief Security Officer

Oscar is a highly-decorated former Detective from Washington D.C. and a former United States Marine. Oscar has served three tours of duty in Afghanistan as a DOD contractor. Oscar is a specialist in communication and intelligence and was deputized with the Department of Justice. His awards include merits of service, letters of commendation and more.

Greg Kosater R.Ph.

Chief Clinical Officer

Greg Kosater is a registered pharmacist with over 35 years of experience in the healthcare industry. Greg has extensive experience in both the clinical and operational aspects of retail, PBM, workers' compensation and the hospice and palliative care lines of business. Greg has numerous professional affiliations including the University of Georgia's College of Pharmacy Advisory Board

The Dream Advisory Team

  • Canna Advisors - the #1 cannabis consulting firm, assists entrepreneurs win licenses, optimize facility design, standardize operations, maximize business development and more
  • Constance Therapeutics - the premier national physician-recommended award-winning and patent-pending medicinal cannabis brand; makes the best standardized medicinal cannabis extracts in the industry
  • Landmarc Strategies and Paladino Public Affairs - our well respected Florida lobbyists based in Tallahassee & Tampa Bay
  • Florida for Care - founded in 2014 to advocate for the implementation of a strong, well-regulated, Florida medical marijuana system under Amendment 2
  • Battaglia, Ross, Dicus & McQuaid, P.A. - corporate legal counsel
  • Cohen Kotler, P.A. - cannabis legal counsel
  • McAtee & Associates, CPAs, P.A. - business accounting firm
  • We have secured the mentoring of Canna Advisors and brought them on the team. Canna Advisors is the pre-eminent cannabis consulting firm in the nation. They have helped more businesses win licenses, navigate the cannabis regulatory environment, and advocate for the cannabis industry.
  • In February, the National Cannabis Industry Association (NCIA) presented Canna Advisors with their Industry Excellence Award for upholding exemplary community engagement, political advocacy and education within the industry
  • Canna Advisors was ranked the #1 Cannabis Consulting Company by the CBE (Cannabis Business Executive)
  • The firm's winning history includes dozens of license wins spanning 20 competitive markets.
  • Canna Advisors continues to set new benchmarks for success with its professional team, offering more than 70 years of combined regulatory experience.

Constance Finley

Constance Finley, founder of Constance Therapeutics, after suffering from a debilitating auto-immune disorder and following a harrowing regimen of traditional treatment, turned to growing her own strains of legal medical cannabis despite her concerns regarding the stigma. After recovering her own quality of life, doctors referred patients suffering from a variety of illnesses to Constance for relief and Constance Therapeutics was born. Through standardization and ISO 9000 pharmaceutical techniques, Constance Therapeutics has been able to provide a consistent brand through a patented process.

About Constance Therapeutics

Constance Therapeutics is a vertically integrated medicinal cannabis company producing standardized and science-based whole-plant cannabis extracts. The company has created a new category of whole-plant cannabis extracts that fills the gap between traditional pharmaceuticals and commonplace cannabis products, providing much needed additional treatment options to physicians and their patients.

Constance Therapeutics' extracts are derived from fully trimmed, female unfertilized cannabis flowers of plants with known genetics using certified-organic, pharmaceutical-grade ethanol via a highly controlled, quantitatively-defined and patented process that is based on solid scientific and engineering principles. Extracts are systematically third-party tested and routinely cross-tested in the industry's most respected laboratories. Since 2008, the company has employed stringent, science-based processes and standards to ensure the highest quality and consistency.


CT pioneered the 4:1 ratio broadly adopted for cancer in the industry, and later the 1:1 ratio now pervasive in the industry; founder Constance Finley led the first-ever SXSW panel on cannabis in 2015; and CT received the first cannabis manufacturing permit in the city of San Francisco.

"If you find something that helps, we can do it again, exactly the same, from the same grower, from the same genetics, to the exact same measurements by weight, so that you can find a reliability." - Constance Finley

Constance Finley is an international speaker on topics such as "Taking cannabis seriously" and "The Future of Botanical Medicine".

Now is the time for medicinal cannabis


  • Recent regulatory momentum in the Florida medical cannabis industry makes it an opportune time to invest in the market.
  • On June 9th, the Florida Legislature approved a bill establishing a framework for the state's constitutional amendment expanding medical marijuana.
  • The bill was officially signed into law by Governor Rick Scott on June 23rd, 2017.
  • Current regulation requires cannabis distributors to be vertically-integrated in order to secure a license to sell medical marijuana in Florida.
  • The company is a member of Florida for Care and has hired Tallahassee & Tampa Bay based lobbyists to represent the company and to stay abreast of all regulatoryactions and maneuvers.

Recent Medical Marijuana Headlines in Florida

Florida Legislature finally passes medical marijuana bill

First Coast News-Jun 10, 2017

Gov. Rick Scott signs medical marijuana bill into law

Orlando Sentinel-Jun 23, 2017

What are the current stats on Florida medicinal cannabis?

OMMU by the Numbers Current Total
Patients in the Registry 83,503
New patients in last 2 weeks 2,384
Qualified Physicians 1,186
Approved Medical Marijuana Treatment Centers 13
Approved Retail Dispensing Locations 28

Note: The medical cannabis environment is changing rapidly with new updated numbers every day. For the latest updates, information and counts on licenses, patient registrations and active facilities in Florida, see the Office of Medical Marijuana Use link here:

Frequently asked questions on medical cannabis can be found at the bottom of the page

Now is the time for medicinal cannabis...did you know...

  • Medical cannabis is more than mainstream in its popular acceptance.
  • Cannabis is now legal in 30 U.S. states plus the District of Columbia.
  • While states have legalized cannabis in sweeping fashion, they are still working out the laws and practices for licensing, sourcing, distribution, taxation, and regulation of legal cannabis. No single brand has emerged as the dominant market share force.
  • American opinion is 94% in favor of medical cannabis and 75% of Americans oppose federal government interference with states that have approved it. (Quinnipiac University Poll, August 3, 2017)

The medical benefits of cannabis

The healthful properties are available for the first time since the 1930's

While the FDA has not recognized or approved the cannabis plant as medicine, as the FDA would require many more clinical trials to assess the benefits and detriments, they have approved two medications that contain cannabinoid chemicals. Cannabidiol, CBD, a non-psychoactive, non-toxic chemical in cannabis, has been suggested to stop cancer cells from spreading. (2007 study by Molecular Cancer Therapeutics) Scientists are currently conducting preclinical and clinical trials with cannabis and its extracts to treat the symptoms of:

  • diseases that affect the immune system, including HIV/AIDS and multiple sclerosis (MS), which causes gradual loss of muscle control
  • inflammation
  • pain
  • seizures
  • substance use disorders
  • mental disorders

Medical cannabis has been used to treat:

  • Temporary pain and soreness
  • Neuromuscular discomfort
  • Sleeplessness
  • Seizures
  • Muscular Sclerosis
  • Post Traumatic Stress Disorder
  • and more

Benefits of Medical Cannabis (with no side effects)

Have you heard of the human (ECS) endocannabinoid system?

Like the circulatory system, the respiratory system, and the lymphatic system, the endocannabinoid system is a biological system in humans. Composed of endogenous lipid-based retrograde neurotransmitters throughout the nervous system and brain, the ECS regulates important processes:

  • fertility
  • appetite
  • sleep
  • pain-sensation
  • mood
  • Memory

Cannabinoids promote homeostasis in many human systems. Cannabis contains at least 113 cannabinoids including CBD (cannabidiol) and THC which researchers suggest support the human endocannabinoid system in a variety of ways. With the legalization of cannabis, homeopathy has a renewed interest in the supplemental and/or healing effects of cannabis. The CBD market now legal in 50 states is rapidly growing and estimated to be a $2.1 billion market in 2020 (700% growth in 4 years.)

Medical cannabis provides relief from the opioid epidemic

  • The United States sees more than 12.7 million new cancer cases a year1 - and among those who must undergo surgery, one in 10 will become dependent on opioid pain relievers2.
  • America's opioid epidemic kills 116 people everyday from lethal overdoses and dependence on pain medications is a close rival to cancer itself as a serious threat to patients' lives.
  • 2.1 million people have an opioid use disorder3.
  • More than 3 out of 5 drug overdose deaths in the U.S. involve an opioid4.
  • International Agency for Research on Cancer (IARC)
  • University of Michigan
  • U.S. Department of Health and Human Services
  • Centers for Disease Control

Better pain management alternatives are available in medical cannabis

A new study published in the European Journal of Internal Medicine, explored the effectiveness of cannabis for cancer patients.

"Cannabis is a very good alternative to reduce opioid consumption, to increase quality of life, and to reduce pain, nausea and vomiting," says Lihi Bar-Lev Schleider, lead researcher on the study.

"If you look at this study and you're a doctor and your patients are suffering with opioids, you'd be hard pressed not to give them cannabis . . . The same for steroids, or any sleep medication. You see the quality of life was so staggering that you should consider cannabis."

Sid Taubenfeld, CEO of Tikun Olam Pharma, United States


GCCM aims to be a vertically-integrated distributor of a complete offering of medical cannabis products to the Florida market. Below is a representative sample of the Company's product offerings.

These products are created using chilled ethanol to extract cannabinoids such as THC and CBD. This allows for more controlled formulations and higher cannabinoid levels than those traditionally found in raw flowers.
These products are created without using traditional solvents to extract the chemical compounds of the plant. This allows for more controlled formulations and higher cannabinoid levels than those traditionally found in flowers.
Vaporizers and other devices that allow patients to easily inhale medicinal vapor from cannabis flower or concentrated oils have become popular options for medicating.
Cannabis infused lotions, balms, oils, salves or patches that are absorbed through the skin and provide localized relief to areas of the body where they are applied. Most topical products do not yield any psychoactive effect.
Stable food grade chilled ethanol-based infusions (i.e. olive oil or coconut oil) that are ingested orally or absorbed sublingually. They can be easily formulated to allow patients maximum control over dosing and symptom relief.
Infused capsules, tablets and liquids that contain cannabis extract, which is digested and absorbed into the bloodstream through the digestive tract. These products are expected to be popular in Florida because they are common and long-established forms of medication
Items that feature the company logo, including, but not limited to: clothing, hats and caps, other wearable accessories such as sunglasses, branded vaporizer pen batteries, etc.

Already in place


With our team in place we already raised $200,000 from our founders and started the licensing procedure. We are working with Canna Advisors, known for the high success rate in licenses approval and partner with Constance Therapeutics, the world leader in Medical Marijuana.

The Advisory Team

Canna Advisors was named the #1 Consulting Firm in 2017 by Cannabis Business Executive. The company has helped drive policy and consulted emerging businesses across the world and is known nationally for their high success rate in securing medical marijuana licenses. They only work with a limited number of well-qualified group.

Constance Therapeutics

Constance Therapeutics produces whole plant cannabis extracts as part of an integrative approach to treatment. It is the first cannabis extraction producer to be awarded a manufacturing permit in the city of San Francisco, California. The company has implemented extensive Standard Operating Procedures (SOPs) and is currently implementing internationally accepted standards for pharmaceutical companies (ISO 9000)

Secured Property

Our team has secured property for cultivation, a 34,000 foot warehouse retrofitted for indoor grow in addition to a 10,0000 square foot green house. We've secured an ideal extraction location, plus two prime dispensary locations which meet zoning approval requirements.

Affiliations industry connections

Use of proceeds

Proceeds from the fundraising will be used for working capital, marketing and promotional expenses, inventory, product development, community outreach and educational information, mergers/acquisitions, and general corporate expenses.

When Target Amount Raised

Operation Expenses 20.0%

When Max. Amount Raised

Operation Expenses 20.0%


Lori Daugherty
Lori Daugherty2 years ago
  1. How many vertically integrated Medical Marijuana Treatment Center (“MMTC”) licenses have been issued in Florida?
  2. As of February 23, 2018, there are 13 approved MMTC licenses with a combined total of 27 approved dispensary locations, and those dispensary locations are all owned by only 5 of the 13 approved MMTC. The other 7 MMTC have yet to open a dispensary. 


  1. How many dispensaries may an approved MMTC operate?
  2. Licensed MMTC may not establish or operate more than 25 dispensing facilities unless the patient registry reaches more than 100,000 patients at which time, and at the time of each additional 100,000 patients, the statewide maximum number of dispensing facilities per MMTC increases by 5.


  1. How many more MMTC licenses are expected and when?


  1. Originally, 7 licenses were approved in 2014 under the low-THC rules. In 2017, pursuant to Senate Bill 8A, the legislation required the Department of Health (“DOH”) to issue licenses to an additional 10 applicants.  First priority of those ten applicants went to applicants that applied in 2014 under the low THC rules and whose application was reviewed but denied a license and that is how the additional 6 licenses were granted in 2017.  According to 8A, by October 3, 2017, the DOH was to license the remaining of the 10 (thus 4) applicants that met the criteria in 8A, plus name an additional 4 “contingent” licenses based on patient count.  The additional 4 contingent MMTC’s were to be licensed within 6 months of the patient register reaching 100,000 patients, and furthermore, an additional 4 MMTC’s are to receive a licensure within 6 months of each additional 100,000 patients.   Obviously the DOH has failed to meet these October 2017 deadlines and there is currently uncertainty as to when they will meet these requirements imposed by 8A.  Thus, upon the patient count reaching 100,000 there should be 8 new licenses issued with 4 more contingently named and ready to proceed upon the patient count reaching 200,000.    Furthermore, an additional 4 MMTCs will be licensed within 6 months of each additional 100,000 patients.


  1. What restrictions may a county/municipality place on a MMTC’s operation?


  1. Generally, the regulation of cultivation, processing, and delivery of marijuana is preempted to the state except that an MMTC may not be located within 500 feet of the real property of a public or private elementary, middle, or secondary school unless a city or county determines that the location promotes the public health, safety, and general welfare of the community. However, the MMTC application does require “preapproval” from the city/municipality in which it intends to cultivate and a local jurisdictions may ensure that MMTC facilities comply with the Florida Building Code, the Florida Fire Prevention Code etc.


In regard to dispensaries, a county or a municipality may ban MMTC dispensing facilities from locating within the boundaries of that county or municipality but - absent a complete ban of dispensing facilities- a county or municipality may not otherwise restrict the number of dispensing facilities that may locate within that county or municipality.  Fortunately, the City of St Petersburg has been working with us favorably in establishing our facilities here in Pinellas County.


  1. What is the current patient/doctor ratio and how can I track the current status?


  1. As of March 2, 2018, the ratio is 83,503 registered patients and 1,186 qualified physicians.  The Florida Department of Health, Office of Medical Marijuana provides weekly updates as to those numbers on the following link:

Load More


You must be logged in to be able to post a question.

David Jackson
David Jackson - Investorone year ago
How do I add to my investment?
Reginald Weaver
Reginald Weaver - Investor2 years ago
under crowdfunding can your investments be transferred from like real estate to dispensary?
Jorge L Garcia
Jorge L Garcia - Investor2 years ago
I have not been refunded my original investment, could you please check what is causing the delay?
Jorge L Garcia
Jorge L Garcia - Investor   
Never mind, I see now that you refunded my funds. Thanks and good luck.

2 years ago
Oscar De La Rosa
Oscar De La Rosa - Issuer    
I have not been refunded my original investment, I will like to get an update please

2 years ago
Lori Daugherty
Lori Daugherty - Issuer    
Good afternoon Oscar,

All funds have been returned at this point in time. There may be an issue with your address or account number used to return those funds so please contact us via email at And we can take care of everything over email so your personal information is kept private.

2 years ago
Shirley Holmes
Shirley Holmes - Investor2 years ago
Hello, it says that goal met, but you're accepting over subscriptions. So if I wanted to go ahead & invest, how and where do I do that?
Lori Daugherty
Lori Daugherty - Issuer    

Good afternoon Shirley,

If you are an accredited investor we do have a PPM that you can take part in. Accredited investors are as defined by the SEC to be a natural person who has individual net worth, or joint net worth with the person's spouse, that exceeds $1 million at the time of the purchase, or has assets under management of $1 million or above, excluding the value of the individual's primary residence. Or a natural person with income exceeding $200,000 in each of the two most recent years or joint income with a spouse exceeding $300,000 for those years and a reasonable expectation of the same income level in the current year.

If any of these apply to you then we will be happy to get you more information on how to invest further. If not, then unfortunately at this time we do not have any other platform to invest through. Please feel free to reach out via email at for any further information.

2 years ago
Marco Ramirez
Marco Ramirez - Investor2 years ago
Hello, I invested in March of this year. From what I am reading, I see there is a problem with escrow. Can I get an update on my account?
Lori Daugherty
Lori Daugherty - Issuer    

Good afternoon Marco,

All money has been returned from the escrow to the investors at this time. If you have not seen that return please contact us via email at and we can verify your account information.

2 years ago
Nelson Perez- Valledor
Nelson Perez- Valledor - Investor2 years ago
Why was my original $3000 investment returned to me???..... thank you
Lori Daugherty
Lori Daugherty - Issuer    
Hello Nelson,

Thank you for your continued interest and previous investment in Gulf Coast Canna Meds. While medical marijuana is legal in Florida, federal law continues to prohibit many aspects of marijuana transactions, one of which is interstate escrow accounts. Therefore, as a technicality, unfortunately, Gulf Coast Canna Meds, is prohibited from moving your recent investment out of the escrow account. This leaves us with little wiggle room when it comes to Crowdfunding and transferring investments from escrow as many banks do not wish to touch funds directly associated with Cannabis Distributors as it is not federally regulated. Please let me know if you have any questions and I will be happy to help!

2 years ago
Dean Bartosh
Dean Bartosh - Investor2 years ago
Lori -

I am so bummed that you had to cancel my investment because of regulations. I still wish all the best to your and your team!

However, it has been about 3 weeks since I got the notification. When will the funds be refunded?

Lori Daugherty
Lori Daugherty - Issuer    
Hello Dean,
We do apologize for the delay in receiving your refund. We have been told by the Escrow that all ACH/Wire transfers should be complete and returned to your account at this point in time if that was the way you invested. If you wrote a check, those checks haven in fact been cut and sent out, the arrival time will just vary as they had many to process and send out. Please also let us know if you believe your address or bank information may be the issue and we can confirm what we have on our end.

2 years ago
Bernard Ogon
Bernard Ogon - Investor2 years ago
I would like to know why my investment was cancelled. I sent in my funds long before you exceeded your funding goal.
Lori Daugherty
Lori Daugherty - Issuer    
Hello Bernard,
We have responded to your question via the email you sent. Please let us know if you have any further questions. Have a great day!

2 years ago
Craig Bentley
Craig Bentley - Investor2 years ago
I haven't seen or heard any updates for some time now. Wondering what is happening??
Lori Daugherty
Lori Daugherty - Issuer    
Good afternoon Craig, At this point, the money is still sitting in the escrow, we have some securities regulatory issues that we need to clear before completing the transactions. We do thank you for your investment with us and your continued interest, it is much appreciated. Currently, we are continuing to perfect our application to submit to the state for a MMTC license. The state has yet to begin accepting applications but we hope and anticipate that they will begin this process in the Fall of this year. Obviously we cannot begin the business of cultivating cannabis until we are approved by the state of Florida as a successful applicant. We will continue to update investors as we follow the state’s progress. Stay up to date with current news by visiting our facebook page or website. Below is also a link to a useful site regarding license and application information. Hope all this information was helpful and please let us know if you have any further questions. Gulf Coast Canna meds:

2 years ago
ANAND PRASAD - Investor2 years ago
Hello there, I know that the target has reached. I'm looking to invest and I see you are accepting subscriptions, How will i be able to invest for that or when will you open up any further investors. Any help is and/or suggestion is appreciated . Thanks
Lori Daugherty
Lori Daugherty - Issuer    

Good afternoon Anand,

Thank you for your interest in GCCM. Upon hitting our minimum target very early on, we did accept over subscriptions. However, the offering closed on 5/1/2018 and we are no longer accepting investments.

2 years ago
Edward Schaeffer
Edward Schaeffer - Investor2 years ago
Can investors check on the status of obtaining the license? Where would we find this information? Thank you.
Lori Daugherty
Lori Daugherty - Issuer    
We are currently just waiting on Florida to release the licenses. As they have yet to be released, no one has been able to apply but we anticipate seeing them released before the end of summer. In the meantime we are preparing our application to be sure there are no flaws and we receive 100% approval. You can also visit our website and the OMMU website for further updates. See links below. Hope all this information helps!


Gulf Coast Canna Meds:

2 years ago
William Olson
William Olson - Investor2 years ago
Are you still accepting investments?
Victor Bonilla
Victor Bonilla - Issuer 2 years ago
I got 50 shares but the money was never taken out yet
Lori Daugherty
Lori Daugherty - Issuer    
A response regarding the status of your account and shares has been sent to your private email. Please let us know if you have any further questions!

2 years ago
Victor Bonilla
Victor Bonilla - Issuer 2 years ago
I got 50 shares by my payment still haven’t when through why is that
Robert Ferramosca
Robert Ferramosca - Investor2 years ago
I don't provide SS# or Driver's License # over the Internet. Will be glade to mail check for 40 shares. Please advise.
Lori Daugherty
Lori Daugherty - Issuer    
Hi Robert,

We totally understand your concern, that is why we made sure that is using SSL to fully encrypt all the messages, therefore your information is safe. Please feel free to contact us via email for any further information.

2 years ago
Hans Joachim Hoeltge
Hans Joachim Hoeltge - Investor2 years ago
i claimed 200; 200; 500 shares
i sent with transferwise 1000 Dollar
1000 Dollar
3000 Dollar
never again heard of the money.
i sent the whole sum 5000 Dollar with my housebank
the money was sent back
a small sum of shares from nextr was successfull paid with similar formulars

i sent 5000 Dollars withe HiFX some days ago and let controll the formulars by fundanna
the money was sent back, only a small sum vanished

i sent for my stepdaughter 1000 Dollars with the housebank and full correct formular-- the money was rejected
my housebank collected for every transaction about 100 Dollar
and i have no single share
best greetings
Hans Joachim Hoeltge
Hans Joachim Hoeltge - Investor   
Now it is all cleared.Fundannas Vincent helped and worked intensive to fix it and we got it.The problem was
,that US-Banks and European Banks seems not fit together well.Wish you now best success.

2 years ago
I made an investment. I just wanted to confirm it was accounted for? You can look up my name. using the account name for this. Please can someone send me an email if that was confirmed?
I made an investment. I just wanted to confirm it was accounted for? You can look up my name. using the account name for this. Please can someone send me an email if that was confirmed?
George W Cole
George W Cole - Investor2 years ago
Hello Lori, I noticed that the funding round has been extended another 20 days. Is this correct? Will you put out an update concerning this? Is the extension due to the possibility of not reaching the desired max of $1070K? I was going to invest today 03/31 by midnight but I noticed the extension of 20 days giving me more time. There is no doubt in my mind that I will be investing in GCCM and am very excited about the potential for the company after doing ample research on my own.
Is Canna Advisors involved with any of the other potential candidates for a license in Florida? I'm going to assume that they aren't but thought I would ask?
I'm looking forward to your reply.

Thank you and Best regards,

George W Cole
Lori Daugherty
Lori Daugherty - Issuer    
We extended the time available to invest as there was a good probability of reaching the cap of 1070 million by the end of the additional 20 days. Please note that as of this email we are currently at approximately $920,000 which leaves us with about $150,000 remaining to invest and at the rate we are receiving investments we hope to be fully committed very soon. As for Canna Advisors, it is our understanding that we are the only Florida applicant involved with them. Please let us know if you have any further questions!

2 years ago
Luis Valdez
Luis Valdez - Investor2 years ago
I invested on 3/29 says pending review. I want to make sure I make the cut off time line.
Lori Daugherty
Lori Daugherty - Issuer    
“Thanks for your investment, Louis. All looks good.”

2 years ago
P&C StratComm
P&C StratComm - Investor2 years ago

Hello Lori,

If "check" is selected as the payment manner, will your company honor/include checks received after this weekend?  Rather apprehensive about the ACH security and would feel safer via a check.  Thank you for your feedback.

Evon Bye
Evon Bye - Investor2 years ago
Where do I go to invest and what would be the return time and amount?
Lori Daugherty
Lori Daugherty - Issuer    


Thank you for your interest in Gulf Coast Canna Meds. To invest, please use the green "Invest" button on the top right of the page. You will find more information on the investment by visiting the section below the video that reads "Investment type" to learn about the security we are selling. Please feel free to contact us back if you have any further questions and we will be happy to assist!


2 years ago
Jeff Park
Jeff Park - Investor2 years ago
Hi Lori,

I am reposting my questions from last week.

Thank you for answering my previous questions in detail. A few more questions before I pull the trigger.
7.  Do any employees currently receive a salary?
8.  Regarding the contingency plan, the offering circular states:

“Should the Company not acquire a Florida Cannabis license by March 31, 2019, then all investors who have subscribed for Common Shares through this Offering shall be provided a specific right to execute a one-time majority vote…”

However, the SAFE in this offering converts into preferred stock.  Does that mean that in the event of the contingency plan, investors in this SAFE will receive voting rights as if their

SAFEs converted into common stock? Please clarify.

9.  When do you anticipate the SAFE to convert into equity?

10.  Does the Revenue Share still continue if the SAFE is converted into equity prior to the total Revenue Share reaching 300% payout (i.e. $15 per RevShare Unit)?

Thanks again!

Lori Daugherty
Lori Daugherty - Issuer    


Here are all the answers to your questions.

7. Do any employees currently receive a salary?

Answer: None of the original investors have received salary/compensation and have contributed on a volunteer basis since the very beginning. Currently, we have one full time employee who works as our administrator on an hourly basis.

8. Regarding the contingency plan, the offering circular states: “Should the Company not acquire a Florida Cannabis license by March 31, 2019, then all investors who have subscribed for Common Shares through this Offering shall be provided a specific right to execute a one-time majority vote…” However, the SAFE in this offering converts into preferred stock. Does that mean that in the event of the contingency plan, investors in this SAFE will receive voting rights as if their SAFEs converted into common stock? Please clarify.

Answer: Thank you for your particular attention to detail and interest in GCCM. That paragraph you reference was left over from the lawyer’s drafting of our original offering under Reg D 505 which section was recently repealed in 2017. The “contingency plan” is in reference to the Common Shares, which are not being offered in this SAFE+REV offering and therefore the paragraph and language is not applicable. The investors in SAFE+REV will get voting rights only in the event of conversion – see the answer below. The Offering Circular will need to be updated to reflect this, i.e., the paragraph regarding the “contingency plan” will be deleted.

9. When do you anticipate the SAFE to convert into equity?

Answer: You are correct in that the SAFE+REV converts to preferred stock pursuant to the SAFE+REV Agreement under certain events, i.e., Liquidity Event, Equity Financing, or a Dissolution Event. While we cannot predict the future, we anticipate that there will be an Equity Financing event at some point in the future and there is the likely possibility of a Liquidity Event as well.

10. Does the Revenue Share still continue if the SAFE is converted into equity prior to the total Revenue Share reaching 300% payout (i.e. $15 per RevShare Unit)?

Answer: There are two separate agreements, and each one will get completed regarding when the other agreement retires. That is, the conversion of the SAFE will not impact the Revenue Participation agreement.

2 years ago
Donald Bolin
Donald Bolin - Investor2 years ago
Hello Lori, So you have on board a qualified (un named) Cultivator to oversee your growing operation and a partnership with Constance Therapeutics to oversee your products / distribution processing operations. What will differentiate GCCM from the established operations already established in Fla. including iAnthus, Liberty Health, Medicine Man. How will you compete with these well established international companies? I am eager to invest it GCCM!
Lori Daugherty
Lori Daugherty - Issuer    
Great questions Donald. Yes, we have a cultivator that has both professional cannabis and native Florida horticulture experience. Currently, we are focused on obtaining a vertical license in FL and competing with the other potential applicants first. Upon licensure, we believe we have identified a niche market that will allow us to differentiate ourselves from the current license holders. As you know, pursuant to the rules in Florida, only a Florida licensed company may cultivate, extract or dispense medical cannabis in Florida.

In regard to competing for a license in Florida:
First, via our original investors’ (Founders) hard work combined with their previous business, healthcare, finance, legal and franchise experience and connections in those industries, GCCM has assembled an excellent team of advisors, consultants, lawyers, and partners to guide us through this application process.
Second, by organizing and implementing the above advantages, the GCCM’s team has been able to satisfy or is in position to satisfy the requirements for licensure listed above. Finally, with the help of Canna Advisors, GCCM will be able to produce a winning application by receiving high scores in nearly every section of the application.

2 years ago
Kevin Wilkenloh
Kevin Wilkenloh - Investor2 years ago
IF marijuana becomes legal at the federal level what does that do to the business?
Lori Daugherty
Lori Daugherty - Issuer    

It would ease banking regulations and potentially tax concerns, (e.g. 280E). But could also allow for larger industries to enter the market, i.e. big pharmaceutical, tobacco and alcohol. 

2 years ago
David Ryan
David Ryan - Investor2 years ago
What happens to investors money if you're unable to obtain a MMTC license and are therefore prevented from accomplishing the stated goals and objectives of Gulf Coast Canna Meds?
Lori Daugherty
Lori Daugherty - Issuer    

Depending on the circumstances, we would continue applying for a license until it was no longer economical even if that meant depletion of investors funds. In the event we decided not to continue applying, we would consider the pro rated return of funds. 


2 years ago
Dean Bartosh
Dean Bartosh - Investor2 years ago
Your team seems to have a good range of experience in the medical and business fields.

However, I don't see anyone with technical expertise in the cannabis/farming/nursery field. Living in Wisconsin, I see a lot of farmers who grow corn - but I certainly wouldn't do it because I lack the experience and technical know-how. How are you planning on bridging this knowledge gap in order to not only grow the plants but process the finished products?
Lori Daugherty
Lori Daugherty - Issuer    
Hi Dean,

Our personnel will include a chief cultivation officer who will be responsible for all components related to the growing of medical marijuana in the state of Florida. This individual has extensive cultivation knowledge and experience and is proficient in the cultivation of medical marijuana. As for processing the finished product, as our pitch deck indicates we have contracted with Constance Therapeutics and will initially use her methodologies and formulations.

2 years ago
Dean Bartosh
Dean Bartosh - Investor   
Thanks so much for the response Lori.

Do you have this cultivation officer yet? Or is the search still on?

2 years ago
Lori Daugherty
Lori Daugherty - Issuer    
Yes, we have an individual committed that meets the specific requirements in the application for the State of Florida. That said and as we grow, GCCM will always be looking for great talent to join our team!

2 years ago
Jeff Park
Jeff Park - Investor2 years ago
Hi Lori,

Thank you for answering my previous questions in detail. A few more questions before I pull the trigger.
7.  Do any employees currently receive a salary?
8.  Regarding the contingency plan, the offering circular states:

“Should the Company not acquire a Florida Cannabis license by March 31, 2019, then all investors who have subscribed for Common Shares through this Offering shall be provided a specific right to execute a one-time majority vote…”

However, the SAFE in this offering converts into preferred stock.  Does that mean that in the event of the contingency plan, investors in this SAFE will receive voting rights as if their

SAFEs converted into common stock? Please clarify.

9.  When do you anticipate the SAFE to convert into equity?

10.  Does the Revenue Share still continue if the SAFE is converted into equity prior to the total Revenue Share reaching 300% payout (i.e. $15 per RevShare Unit)?

Thanks again!

Graham Anderson
Graham Anderson - Investor   
Can I pay for my investment with my debit card?

2 years ago
Lori Daugherty
Lori Daugherty - Issuer    
For US based investors, the investment can be made with wire

transfer, ACH or paper check, for anyone else (non-US) investors only via wire transfer.

2 years ago
Jeff Park
Jeff Park - Investor2 years ago
Hi - I am very interested in investing. A few questions below.

1. How much cash do you currently have? How much runway will you have: a) with current amount raised; b) if you raise the max amount of $1mm?

2. Who is Coast Botanicals?  How much did they invest for 75% of the company?

3. I understand this is difficult to predict, but when do you expect to receive the license from FL (early and late estimates)?

4. How many months will it take to start generating revenue once you obtain the license?

5. Other than working with Canna Advisors on obtaining the license, what activities are in progress to operationalize the company?

6. The valuation document indicates you need $10mm in capital (page 2).  Why do you need this much?  Assuming you raise the max of $1mm on Fundanna, where will the other $9mm come from?

Thanks in advance!
Jeff Park
Jeff Park - Investor   
Additional question:

7. Are any employees currently paid a salary?

2 years ago
Glenn Robins
Glenn Robins - Investor   
Why haven’t these questions been answered?

2 years ago
Lori Daugherty
Lori Daugherty - Issuer    
Hi Jeff, here are the answers:
1) The Founders of GCB, originally invested approximately $1 million of their capital for purposes of beginning the application process. $200,000 of that was used in forming a sub company of Botanicals, i.e., Gulf Coast Canna Meds.
GCCM has the ability to raise additional money outside of crowdfunding, e.g., via a Private Placement or institutional investors.

2) Gulf Coast Botanicals consists of the original founders, who invested approximately $1,000,000 of their capital. Gulf Coast Botanicals owns 75% of Gulf Coast Canna Meds.

3) That is the million-dollar question. We are preparing our application under the assumption that it could be due within 30 days but also anticipating that we might not be able to submit our application until potentially 2019. At this point the DOH has released a version of the application (although it could change) and we currently making final preparations to ensure that we have everything required for application purposes. The application is very specific as to how many words can be used to answer each question, how many points each question is worth, and what must be redacted (anything that could potentially identify a particular applicant and thus create an unfair bias in the grading system). According to the DOH, the applications will be graded by an independent third party using a blind grading system. Upon the DOH accepting applications, we anticipate 30 days to submit the application and then another 60 days for the review/grading process. See attached link to a copy of the application. Also see the Feburary 1st linked Sun Sentinel discussion the confusion over this very issue.

4) Prior to planting the first seed, a MMTC must have their cultivation center approved by the DOH, i.e., to ensure the cultivation center meets all requirements imposed by the DOH. Upon being planted, seeds take approximately six months until harvest.

5) Establishing strategic relationships with partners such as Constance Therapeutics and other potential intellectual property partners with idea being that they will assist us in developing proven successful products from the beginning. Securing (including zoning pre-approvals) properties for cultivation, processing and dispensing as required for licensure. Currently we have the secured a cultivation location, an extraction location and two dispensing locations. These locations need to be built out pursuant to specification. We are continuing to look for additional suitable dispensary locations while balancing current cash flows. Additional, we continue working with the community to provide education, e.g., in the area of PTSD for veterans.

6) The application requires the MMTC have the ability to sustain operational costs for two years as well as requires that we obtain a $5 million performance bond within 10 days of receiving a license. Additionally, in the event of a tie breaker in the scoring system, the first tie breaker looks to the applicant’s financials. Via the founders original capital investment we raised over $1 million dollars. Additionally, we are able to raise another $1,070,000 in crowdfunding from Florida resident investors. We can raise up to $2 million via a Private Placement (Regulation D) through accredited investors as well as unlimited amounts via institutional investors. The $10 million mark would be ideal but if less than that was raised we would have to slow down on development of additional

2 years ago
Alan Jacobson
Alan Jacobson - Investor2 years ago
Hi, you are certainly in a market with great potential, and if I'm reading correctly investors get a 3x return and then also retain equity after that. I am also interested to hear more about the team, as Michael asked. Also, this is very early stage, and all you'll have is 200K plus what you raise here. How much money will you need in addition to that to make that P&L a reality, and what would the timeline be after this close? Is 5% on gross revenue? Finally, I don't know much about the regulatory environment - are there hurdles beyond financial that could stop this project, and how far along are you with regard to those? Thanks!
Lori Daugherty
Lori Daugherty - Issuer    
Correct, 3x return based on 5% of gross revenue starting at the beginning of 2020, which we conservatively anticipate is when we will begin receiving revenue.
Very understandable question regarding more information on management, we have updated the content (by hiring a professional to write the content) and included additional content detailing the management team, of which we are very proud.
Via the founders original capital investment we raised over $1 million dollars. Additionally, we are able to raise another $1,070,000 in crowdfunding from Florida resident investors. We can raise up to $2 million via a Private Placement (Regulation D) through accredited investors as well as unlimited amounts via institutional investors. The $10 million mark would be ideal but if less than that was raised we would have to slow down on development of additional dispensaries etc. The crowdfunding idea was a way to involve our friends and family that didn’t have large sums of disposable income.
Yes, the current Florida as well as the Federal regulatory environment are huge potential hurdles in addition to a long list of other issues, see e.g., question 6 of the Q&A. However, ultimately we feel confident that we can submit a qualified application for obtaining an MMTC vertical license when the state begins accepting those applications otherwise we would not be in this business

2 years ago
Dean Bartosh
Dean Bartosh - Investor2 years ago
I see a lot of potential in this market and I wish all the best to you!

My questions have to do with the regulatory hurdles that lie ahead for you. It seems that companies like Surterra Therapeutics, Modern Health Concepts and others in the Florida cannabis cartel already have a pretty strong foothold in the state. It's also apparent that the Florida OMMU is months behind in issuing the licenses and dragging their feet.

What factors lead you to believe that you will be able to obtain one of the few licenses - especially in the face of so much competition for the remaining licenses and the fact that you're a relatively new company without a longer history of farming in Florida?
Michael Sontheimer
Michael Sontheimer - Investor2 years ago
There are no credentials for your team. Only their postion and personal opinion on the topic of med marijuana which is obvious. Experience? Previous work? Education? Anything that might lead an investor to have confidence in their abilities?
Lori Daugherty
Lori Daugherty - Issuer    
Hello Michael! On our website we have all the information that you are inquiring about. Our website is Please feel free to contact us with any additional questions.

2 years ago


Form C and Offering Statement View Download
Valuation Report View Download

Other Disclosures

Read the Form C filed with the SEC for other important disclosures, like financial statements, Directors, Officers, shareholders with more than 20% of voting rights, and more.
Use of Proceeds
The allocation of the use of proceeds among the categories of anticipated expenditures represents management’s best estimates based on the current status of the Company’s proposed operations, plans, investment objectives, capital requirements, and financial conditions. Future events, including changes in economic or competitive conditions of our business plan or the completion of less than the total Offering, may cause the Company to modify the above-described allocation of proceeds. The Company’s use of proceeds may vary significantly in the event any of the Company’s assumptions prove inaccurate. We will retain broad discretion in the allocation of the net proceeds from this Offering, reserve the right to change the allocation of net proceeds from the Offering as unanticipated events or opportunities arise and could utilize the proceeds in ways that do not necessarily improve our results of operations or enhance the value of our Common Stock. Additionally, the Company may from time to time need to raise more capital to address future needs that we may not have anticipated as of the date of this Offering Circular.
Special Note Regarding Forward-Looking Statements
This offering contains forward-looking statements within the meaning of the federal securities laws. We caution investors that any forward-looking statements presented in this offering, or which management may make orally or in writing from time to time, are based on the Company’s beliefs and assumptions made by, and information currently available to, the Company. When used, the words “anticipate,” “believe,” “expect,” “intend,” “may,” “might,” “plan,” “estimate,” “project,” “should,” “will,” “would,” “result” and similar expressions, which do not relate solely to historical matters, are intended to identify forward-looking statements. Such statements are subject to risks, uncertainties and assumptions and are not guarantees of future performance, which may be affected by known and unknown risks, trends, uncertainties and factors that are beyond the Company’s control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. While forward-looking statements reflect the Company’s good faith belief when made, they are not guarantees of future performance. The Company expressly disclaims any responsibility to update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this offering may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. We undertake no obligation to revise or publically release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements.

Back to top